GABRIELLE VINCENT: Open Payments
NPI 1962082156 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,012 in 27 payments from 8 companies in 2025. Trend: 2023 $16 · 2024 $844 · 2025 $1,012
Food & beverage: $1,012
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 14 | $532 |
| ViiV Healthcare Company | 4 | $187 |
| Braeburn Inc. | 1 | $125 |
| Exact Sciences Corporation | 4 | $87 |
| Indivior Inc. | 1 | $23 |
| Neurocrine BioSciences, Inc. | 1 | $20 |
| ABBVIE INC. | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $19 |
Products named: Epclusa, DOVATO, BRIXADI, Yeztugo, Cologuard Collection Kit, APRETUDE, SUBLOCADE, INGREZZA.
Industry payments across OH — which companies pay providers there.
